In fall 2020, MIT’s School of Engineering and Takeda Pharmaceuticals Company Limited launched the MIT-Takeda Program, a collaboration to support members of the MIT community working at the intersection of artificial intelligence and human health. Housed at the Abdul Latif Jameel Clinic for Machine Learning in Health, the collaboration aims to use artificial intelligence to both benefit human health and aid in drug development. Combining technology with cutting-edge health research, the program’s participants hope to improve health outcomes across the world. Thus far, the partnership has supported joint research efforts…
